openPR Logo
Press release

Drug Discovery Informatics Market is Forecast to Cross US$ 6 Billion By 2022

02-22-2018 03:04 PM CET | Health & Medicine

Press release from: (MRE) Report

Drug Discovery Informatics Market

Drug Discovery Informatics Market

New York, February 22, 2018: The Global Drug Discovery Informatics Market is expected to exceed more than US$ 6 Billion by 2022.

The Global Drug Discovery Informatics Market is segmented on the lines of its workflow, mode, service and regional. Workflow is further segmentation into development informatics and discovery informatics. Under mode segmentation it covers in house informatics and outsourced informatics. Based on service segmentation it covers clinical trial data management, sequence analysis platforms, docking, molecular modeling and others. The drug discovery informatics market’s geographic segmentation covers various regions such as North America, Europe, Asia Pacific, Latin America, Middle East and Africa. Each geography market is further segmented to provide market revenue for select countries such as the U.S., Canada, U.K. Germany, China, Japan, India, Brazil, and GCC countries.

The drug discovery is the method in which new applicant medications are discovered. Drug discovery informatics is used in many fields such as in pharmacology, biotechnology and in medicine. Drug discovery involves the medicinal chemistry, screening hits and optimization of those hits to increase oral bioavailability, metabolic stability, efficacy, selectivity and affinity. With the beginning of innovative analytics and cloud based technology, it is feasible to store, process and analyze huge amount of data sets at lower price.

Browse Full Report: https://www.marketresearchengine.com/reportdetails/drug-discovery-informatics-market

The major driving factors of Global Drug Discovery Informatics Market are as follows:

• Information technology development in the field of data mining and methodical with respect to drug expansion
• Structured and unstructured data detonation
• Increasing usage of cloud based services

The restraining factors of Global Drug Discovery Informatics Market are as follows:

• Increasing chronic illness

This report provides:

1) An overview of the global market for Global Drug Discovery Informatics Market and related technologies.
2) Analyses of global market trends, with data from 2013, estimates for 2014 and 2015, and projections of compound annual growth rates (CAGRs) through 2020.
3) Identifications of new market opportunities and targeted promotional plans for Global Drug Discovery Informatics Market.
4) Discussion of research and development, and the demand for new products and new applications.
5) Comprehensive company profiles of major players in the industry.

The report covers detailed competitive outlook including the market share and company profiles of the key participants operating in the global market. Key players profiled in the report include Infosys, Certara, Charles River Laboratories, Boehringer Ingelheim GmbH, Albany Molecular Research, Selvita, DiscoverX, GVK Biosciences, ChemAxon, Novo Informatics and Jubilant Biosys. Company profile includes assign such as company summary, financial summary, business strategy and planning, SWOT analysis and current developments.

The scope of the report includes a detailed study of global and regional markets for Global Drug Discovery Informatics Market with the reasons given for variations in the growth of the industry in certain regions.

Request Sample Report: https://www.marketresearchengine.com/reportdetails/drug-discovery-informatics-market

Table of Contents

1 INTRODUCTION
2 Research Methodology
3 Executive Summary
4 E-Prescribing Market : Premium Insights
5 Market Overview
5.1 Introduction
5.2 Key Market Dynamics
5.2.1 Market Drivers
5.2.1.1 Government Initiatives & Incentive Programs
5.2.1.2 Rising Focus on the Reduction of Fraud & Abuse of Controlled Substances
5.2.1.3 Focus on Reducing Medication Errors
5.2.1.4 Need to Curtail Escalating Healthcare Costs
5.2.2 Restraints
5.2.2.1 High Cost of Deployment
5.2.2.2 Reluctance to Adopt New Technology
5.2.2.3 Security and Workflow Issues
5.2.3 Opportunities
5.2.3.1 Services Industry to Provide Opportunities for Revenue Generation
5.2.3.2 APAC Markets to Register High Growth
5.2.4 Challenge
5.2.4.1 Lack of Technological Awareness Among End Users
6 Industry Insights
8 Global E-Prescribing Market, By Delivery Mode
9 Global E-Prescribing Market, By End User
10 Global E-Prescribing Market, By Region
11 Competitive Landscape
12 Company Profiles
Certara
Charles River Laboratories
Boehringer Ingelheim GmbH
Albany Molecular Research
Selvita
DiscoverX
GVK Biosciences
ChemAxon
Novo Informatics
Jubilant Biosys

About Us

Market Research Engine (MRE) is a next-generation provider of syndicated research, customized research, and consulting services. MRE’s global and regional market intelligence coverage includes industries such as pharmaceutical, chemicals and materials, technology and media, food and beverages, and consumer goods, among others. Each Market Research Engine’s research report provides clients with a 360-degree view of the market with statistical forecasts, competitive landscape, detailed segmentation, key trends, and strategic recommendations.

Media Contact

Company Name: Market Research Engine
Contact Person: John Bay
Email: john@marketresearchengine.com
Phone: +1-855-984-1862
Country: United States
Website: https://www.marketresearchengine.com/

Address: 3422 SW 15 Street, Suite #8942, Deerfield Beach, FL 33442, United States

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Drug Discovery Informatics Market is Forecast to Cross US$ 6 Billion By 2022 here

News-ID: 954252 • Views:

More Releases from (MRE) Report

Weight Management Market is Expected To Be Worth US$ 442 Billion By 2025
Weight Management Market is Expected To Be Worth US$ 442 Billion By 2025
New York, March 26, 2018: Weight Management Market 2018 The Global Weight Management Market is expected to exceed more than US$ 442.0 Billion by 2025 at a CAGR of 8.0% in the given forecast period. The scope of the report includes a detailed study of global and regional markets on Global Weight Management Market with the reasons given for variations in the growth of the industry in certain regions. The report covers detailed
Home Healthcare Market is Expected To Be Worth US$ 300 Billion By 2022
Home Healthcare Market is Expected To Be Worth US$ 300 Billion By 2022
New York, March 26, 2018: Home Healthcare Market 2018 The Global Home Healthcare Market is expected to exceed more than US$ 300.7 Billion by 2022 at a CAGR of 7.4% in the given forecast period. The scope of the report includes a detailed study of global and regional markets on Global Home Healthcare Market with the reasons given for variations in the growth of the industry in certain regions. The report covers detailed
Healthcare 3D Printing Market is Forecast to Cross US$ 4 Billion By 2022
Healthcare 3D Printing Market is Forecast to Cross US$ 4 Billion By 2022
New York, March 26, 2018: Healthcare 3D Printing Market 2018 The Global Healthcare 3D Printing Market is expected to exceed more than US$ 4 Billion by 2022 at a CAGR of 21.0% in the given forecast period. The report covers detailed competitive outlook including the market share and company profiles of the key participants operating in the global market. Key players profiled in the report include 3D Systems, Arcam AB, Renishaw PLC., EoS
Tumor Ablation Market is Projected to Reach US$ 650 Million By 2022
Tumor Ablation Market is Projected to Reach US$ 650 Million By 2022
New York, March 26, 2018: Tumor Ablation Market 2018 The Global Tumor Ablation Market is expected to exceed more than US$ 650 Million by 2022 at a CAGR of 12.0% in the given forecast period. The scope of the report includes a detailed study of global and regional markets for Global Tumor Ablation Market with the reasons given for variations in the growth of the industry in certain regions. The report covers detailed

All 5 Releases


More Releases for Drug

Alcohol Testing And Drug Testing Equipment Market 2025 Segmentation, Application …
Market Study Report, LLC, has compiled an exhaustive research study of the ‘Alcohol Testing And Drug Testing Equipment market’, detailing every single market driver and intricately analyzing the business vertical. This ‘Alcohol Testing And Drug Testing Equipment market’ study will aid in seeking out new business opportunities and fine-tuning existing marketing strategies through insights regarding SWOT analysis, market valuation, competitive spectrum, regional share, and revenue predictions. Alcohol abuse and drug
How much Diabetes Drug Market Impact Worldwide Medical Drug Industry?
Diabetes Drug Market From an insight perspective, the market report focuses on various levels of analyses — industry analysis, market rank analysis, and company profiles, which together comprise and discuss basic views on the competitive landscape, high-growth regions, and countries as well as their respective regulatory policies, Types ,Applications and opportunities in the market.  Diabetes is a metabolic disorder in which the body glucose level is elevated. There are two types of diabetes
Hepatitis Drug Market Hepatitis Drug Clinical Pipeline Report 2023
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990 Report Table of Contents 1. Introduction to Hepatitis Disease 1.1 Prologue 1.1.1 History of Hepatitis 1.1.2 Causes of Hepatitis Disease 1.2 Types of Viruses which are Responsible for Hepatitis Disease 2. Global Prevalence of Hepatitis Infection 3. Available Drug Classes for Hepatitis Disease Treatment 3.1 Interferon Alfa Therapy 3.2 Protease Inhibitors Therapy 3.3 Polymerase
Microcapsules Drug Delivery Market Microcapsules Drug Delivery Sales Report 2022
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990 Report Table of Contents 1. Indispensable Advent of Microcapsules 1.1 Trajectory of Microencapsulation 1.2 Why and wherefores for Microencapsulation 2. Characterization of Microcapsules 2.1 Composition of Microcapsules 2.2 Parameters Influencing Microcapsules 3. Engineering Technology of Microcapsules 3.1 Physical Manufacturing Technologies 3.2 Physicochemical and Chemical Technologies 4. Applicability of Microcapsules 4.1 Microcapsules in Pharmaceuticals 4.2 Microcapsules in Nutraceuticals
AstraZeneca’s NMOSD Drug receives orphan drug designation
April 18, 2017 Orphan Drug European Medicine Agency has Announced orphan drug designation for inebilizumab (earlier known as MEDI-551) developed by AstraZeneca PLC (AZN) for the treatment of neuromyelitis optica spectrum disorder (NMOSD). The drug has already received orphan drug status from US Food and Drug Administration (FDA). NMOSD, also called Devic’s disease, is a rare, autoimmune disorder of the central nervous system (CNS) that affects the functioning
Drug Discovery Strategies, PBPK Modeling and Drug-Drug Interaction Explored and …
This year’s 12th annual ADMET conference and exhibition promises to deliver appearances from experienced pharmaceutical professionals from ADME and PK/PD organisations such as AbbVie, GSK, Roche and Bayer when it returns to London this June. The carefully selected speaker line up will be addressing early ADME application strategies and discussing the latest technologically advanced screening and testing models along with exploring ADMET technologies which will identify properties of a drug